Gastroenterology
Showing of 10 results
UH Seidman Cancer Center Researcher Awarded New Gastrointestinal Cancer Grant from NCCN in Collaboration with Taiho Oncology, Inc.
Dr. Madison Conces was awarded for a Phase II Clinical Trial of Trifluridine/Tipiracil plus Oxaliplatin in Patients with Advanced or Metastatic Biliary Tract Cancer Following First-Line Therapy.
Researchers at University Hospitals, Case Western Reserve to begin clinical testing with new, less-invasive technology to screen for esophageal precancer
Study supported by $8 million National Institutes of Health grant.
University Hospitals Physician-scientist, Linda Cummings, Selected for American Gastroenterological Association Pilot Research Award
Research will address growing problem of antimicrobial resistance in eradicating Helicobacter Pylori (H. pylori), a bacterial infection that increases the risk of gastric cancer and peptic ulcer disease.
New Research Paper Supports Using Microbiome Data to Develop Potential Probiotic Therapies
In a clinical study, researchers demonstrate a model for developing targeted probiotic therapies to modulate the microbiome
UH Rainbow Babies & Children’s Hospital First in Midwest to Use EvoEndo® System for Pediatric Endoscopy
World's First Single-Use Scope for Unsedated Pediatric Endoscopy
UH Cleveland Medical Center First in Ohio to Receive GI Genius™ AI Endoscopy Modules Through Program Supporting Colorectal Cancer Screening in Medically Underserved Communities
Already first in state with a fully integrated AI endoscopy unit, UH Cleveland Medical Center will receive additional modules awarded through Medtronic's Health Equity Assistance program seeking to improve colon cancer screening and prevention.
Gay Men are Two Times More Likely to Have Inflammatory Bowel Disease, According to New Research
Study will allow researchers to develop personalized precision medicine for treatment of IBD in this underrepresented minority patient population.
Swallowable Device to Detect Pre-cancerous Barrett's Esophagus Receives FDA 510(k) Clearance
Minimally invasive, cost-effective alternative to endoscopy identifies precursor to cancer of the esophagus.